Natural history of adult-onset laryngeal papillomatosis following multiple cidofovir injections

Annals of Otology, Rhinology and Laryngology

Volumn 115, Issue 3, 2006, Pages 175-181

  Naiman, Ana Nusa ^a   Abedipour, Darius ^a   Ayari, Sonia ^a   Fresnel, Elizabeth ^b   Coulombeau, Bruno ^a   Bour, Jean Baptiste ^c   Froehlich, Patrick ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b AMERICAN HOSPITAL OF PARIS   (France)

^c DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Cidofovir; Endoscopy; Larynx; Microdebrider; Papillomatosis; Surgical excision

Indexed keywords

3 INDOLEMETHANOL; ALPHAN1 INTERFERON; CIDOFOVIR; MUMPS VACCINE;

ADULT; CANCER SURGERY; CARBON DIOXIDE LASER; CLINICAL ARTICLE; DEBRIDEMENT; DISEASE COURSE; DRUG EFFICACY; DRUG MEGADOSE; ENDOSCOPY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INJECTION; LARYNX PAPILLOMATOSIS; MALE; MULTIPLE DRUG DOSE; NEPHROTOXICITY; ONSET AGE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; REVIEW; TUBULAR DYSFUNCTION; TUMOR RECURRENCE;

EID: 33644908210     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940611500303     Document Type: Review

References (32)

1. Armstrong LR, Derkay CS, Reeves WC. Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. RRP Task Force. Arch Otolaryngol Head Neck Surg 1999;125:743-8.
2. Lindeberg H, Elbrond O. Malignant tumours in patients with a history of multiple laryngeal papillomas: the significance of irradiation. Clin Otolaryngol Allied Sci 1991;16:149-51.
3. Yoder MG, Batsakis JG. Squamous cell carcinoma in solitary laryngeal papilloma. Otolaryngol Head Neck Surg 1980;88:745-8.
4. Schraff S, Derkay CS, Burke B, Lawson L. American Society of Pediatric Otolaryngology members' experience with recurrent respiratory papillomatosis and the use of adjuvant therapy. Arch Otolaryngol Head Neck Surg 2004;130:1039-42.
5. Pransky SM, Brewster DF, Magit AE, Kearns DB. Clinical update on 10 children treated with intralesional cidofovir injections for severe for severe recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 2000;126:1239-43.
6. Pransky SM, Albright JT, Magit AE. Long-term follow-up of pediatric recurrent respiratory papillomatosis managed with intralesional cidofovir. Laryngoscope 2003;113:1583-7.
7. Akst LM, Lee W, Discolo C, Knott D, Younes A, Koltai PJ. Stepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children. Arch Otolaryngol Head Neck Surg 2003;129:841-6.
8. Chhetri DK, Shapiro NL. A scheduled protocol for the treatment of juvenile recurrent respiratory papillomatosis with intralesional cidofovir. Arch Otolaryngol Head Neck Surg 2003;129:1081-5.
9. Milczuk HA. Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in 4 children. Otolaryngol Head Neck Surg 2003;128:788-94.
10. Peyton Shirley W, Wiatrak B. Is cidofovir a useful adjunctive therapy for recurrent respiratory papillomatosis in children? Int J Pediatr Otorhinolaryngol 2004;68:413-8.
11. Snoeck R, Wellens W, Desloovere C, et al. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2- phosphonylmethoxypropyl) cytosine]. J Med Virol 1998;54:219-25.
12. Bielamowicz S, Villagomez V, Stager SV, Wilson WR. Intralesional cidofovir therapy for laryngeal papilloma in an adult cohort. Laryngoscope 2002;112:696-9.
13. Neumann K, Pudszuhn A, Welzel C, Bartel-Friedrich S, Passmann M. Intralesional cidofovir injections for recurrent laryngeal papillomatosis: first results [in German]. Laryngorhinootologie 2003;82:700-6.
14. Naiman AN, Ceruse P, Coulombeau B, Froehlich P. Intralesional cidofovir and surgical excision for laryngeal papillomatosis. Laryngoscope 2003;113:2174-81.
15. Derkay CS, Malis DJ, Zalzal G, Wiatrak BJ, Kashima HK, Coltrera MD. A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. Laryngoscope 1998;108:935-7.
16. Dedo HH, Yu KCY. CO2 laser treatment in 244 patients with respiratory papillomatosis. Laryngoscope 2001;111:1639-44.
17. Leventhal BG, Kashima HK, Mounts P, et al. Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1. Papilloma Study Group. N Engl J Med 1991;325:613-7.
18. Shikowitz MJ, Abramson AL, Freeman K, Steinberg BM, Nouri M. Efficacy of DHE photodynamic therapy for respiratory papillomatosis: immediate and long-term results. Laryngoscope 1998;108:962-7.
19. Pashley NRT. Can mumps vaccine induce remission in recurrent respiratory papilloma? Arch Otolaryngol Head Neck Surg 2002;128:783-6.
20. Rosen CA, Bryson PC. Indole-3-carbinol for recurrent respiratory papillomatosis: long-term results. J Voice 2004;18:248-53.
21. Grau JJ, Cuchi A, Traserra J, et al. Follow-up study in head and neck cancer: cure rate according to tumor location and stage. Oncology 1997;54:38-42.
22. Frei E III. Curative cancer chemotherapy. Cancer Res 1985;45:6523-37.
23. Wachsman M, Petty BG, Cundy KC, et al. Pharmacokinetics safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects. Antiviral Res 1996;29:153-61.
24. Naiman AN, Roger G, Gagnieu MC, et al. Cidofovir plasma assays after local injection in respiratory papillomatosis. Laryngoscope 2004;114:1151-6.
25. Abdulkarim B, Sabri S, Deutsch E, et al. Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers. Oncogene 2002;21:2334-46.
26. Andrei G, Snoeck R, Schols D, De Clercq E. Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positive cells. Oncol Res 2000;12:397-408.
27. Neyts J, Sadler R, De Clercq E, Raab-Traub N, Pagano JS. The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice. Cancer Res 1998;58:384-8.
28. Abdulkarim B, Sabri S, Zelenika D, et al. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies. Oncogene 2003;22:2260-71.
29. Ossoff RH, Werkhaven JA, Dere H. Soft-tissue complications of laser surgery for recurrent respiratory papillomatosis. Laryngoscope 1991;101:1162-6.
30. Crockett DM, McCabe BF, Shive CJ. Complications of laser surgery for recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 1987;96:639-44.
31. El-Bitar MA, Zalzal GH. Powered instrumentation in the treatment of recurrent respiratory papillomatosis: an alternative to the carbon dioxide laser. Arch Otolaryngol Head Neck Surg 2002;128:425-8.
32. Patel N, Rowe M, Tunkel D. Treatment of recurrent respiratory papillomatosis in children with the microdebrider. Ann Otol Rhinol Laryngol 2003;112:7-10.